Skip to main content

Agios Pharmaceuticals, Inc 10-Q for FY2025 Q3

Agios Pharmaceuticals, Inc. (AGIO)

10-Q 2025-10-30 For: 2025-09-30
View Original
Added on April 10, 2026

About this 10-Q

Agios Pharmaceuticals, Inc filed this 10-Q on October 30, 2025, covering the quarter ended September 30, 2025 (FY2025 Q3).

Headline figures

Quarter ended September 30, 2025, as reported in this filing, compared with the same period a year earlier where the filing states it.

Revenue
$12.88M
up 43.7% from $8.96M a year earlier
Net loss
$103.43M
compared with net income of $947.92M a year earlier
Diluted EPS
-$1.78
compared with $16.22 a year earlier